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Abstract In searching for a candidate mechanism for the im- 
munosuppressive as well as fibrogenic consequences of cy- 
closporine usage, we have explored the hypothesis that cy- 
closporine stimulates transcription of transforming growth fac- 
tor-Ol (TGF-/30, a multifunctional cytokine endowed with im- 
munosuppressive and fibrogenic properties. Our results demon- 
strate that cyclosporine (i) stimulates TGF-I~I promoter-depend- 
ent transcription of chloramphenicol acetyl transferase gene in 
transiently transfected human A-549 cells, (ii) stimulates the syn- 
thesis of TGF-O1 RNA transcripts in human T cells, and (iii) 
permits the expression/emergence of DNA regulatory proteins 
(retinoblastoma control factor-1 (RCF-1) and RCF-2) that bind 
and regulate TGF-~I promoter activity. Our studies demonstrate 
for the first time that cyclosporine stimulates TGF-~I gene tran- 
scription and suggest a novel mechanism of action of cy- 
closporine. 
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1. Introduction 
Cyclosporine (CsA) is a potent immunosuppressant that has 
had a significant impact on organ transplantation [1]. A major 
troubling feature of its clinical usage is fibrosis [1]. In searching 
for a candidate mechanism for the immunosuppressive as well 
as fibrogenic consequences of CsA usage, the hypothesis that 
CsA stimulates transforming rowth factor-ill (TGF-fll) gene 
transcription was explored since TGF-fl~ is not only an ina- 
munoregulatory molecule [2,3] but also a fibrogenic cytokine 
[4]. The scientific underpinning for this provocative postulate 
(CsA is generally considered to be an inhibitor of gene tran- 
scription [5,6]) was provided by our earlier demonstration that 
CsA increases the steady-state levels of TGF-fl~ messenger 
RNA (mRNA) as well as TGF-fl~ protein in mammalian cells 
[7,8]. 
The TGF-fll gene has two well-characterized promoters [9- 
12]. Elegant studies have shown that at least two DNA binding 
proteins (retinoblastoma control factors (RCF)-I  and RCF-2) 
bind to sequences designated as retinoblastoma control ele- 
ments (RCE) [12]. RCF-1 appears to be stimulator protein-1 
(Sp-1) by multiple criteria [12]. It has also been shown that Sp-1 
stimulates TGF-fll promoter activity [13] and that Sp-l-medi- 
ated transcription is regulated by the retinoblastoma gene pro- 
tein [14]. 
We report here that (i) CsA stimulates TGF-fll transcription 
*Corresponding author. Fax: (l) (212) 861-9473. 
and (ii) CsA does not interfere with either the expression of 
RCF-1 or the emergence of RCF-2 in stimulated normal 
human T cells. Stimulation of TGF-fll gene transcription by 
CsA represents the first example of an immunoregulatory gene 
the transcription of which is stimulated in normal human T cells 
by CsA. 
2. Materials and methods 
2.1. Isolation and stimulation of T cells 
Highly purified T cells (> 98% CD2 antigen-positive c lls) were iso- 
lated from normal human peripheral blood mononuclear cells and 
stimulated with a synergistic ombination of sn-1,2-dioctanoylglycerol 
(DAG) and ionomycin, as described [7,15]. The T cells were either 
untreated or pretreated with 100 ng/ml CsA at 37°C for 30 min and then 
incubated for an additional 1 h at 37°C with 10/~g DAG and 1 ¢tM 
ionomycin. 
2.2. DNA probes 
The full-length uman IL-2 cDNA plasmid was a gracious gift from 
Dr. A. Granelli-Piperno, Rockefeller University, New York, NY. Full- 
length human TGF-fll cDNA plasmid phTGFfl-2 was obtained from 
ATCC (Rockville, MD), plasmid phTG5-CAT was a kind gift of Dr. 
S.-J. Kim and Dr. Anita Roberts (NCI, NIH), and the plasmid 
pAct 108, carrying exons 1-3 of the rat fl actin gene, was a kind gift from 
Dr. B. Raghu (Washington University, St. Louis, MO). 
2.3. TGF-fll promoter-dependent transcription 
A-549 human adenocarcinoma cells (A-549 cells), obtained from 
ATCC, were grown in OPTI-MEM (Gibco Laboratories, Grand Is- 
land, NY) supplemented with 5% FBS (culture medium). The cells were 
washed twice with serum-free medium before transfection with the 
TGF-fl~hloramphenicol acetyl transferase (CAT) construct, plasmid 
phTG5, -453 to +11 nucleotide-sequence of human TGF-fll gene fused 
to the coding sequence of the bacterial CAT gene [8]. The transfected 
A-549 cells were washed and incubated overnight with medium alone, 
TGF-fl~, cyclosporine H (CsH) or CsA. TGF-fl~ promoter stimulation 
was quantified by measuring the concentration of CAT enzyme in 
extracts using a CAT-specific ELISA kit (Boehringer-Mannheim, Indi- 
anapolis, IN). 
2.4. Isolation of nuclei and nuclear run Rff" transcription assay 
Nuclear run-on assay was performed according to a method de- 
scribed elsewhere [16]. Briefly, about 100-150 million T cells were lysed 
at 4°C by 0.02% NP-40 in a buffer containing 10 mM Tris-HC1, pH 7.5, 
2 mM MgC12, 3 mM CaCI z and 0.3% sucrose. Nuclei were isolated by 
ultracentrifugation at 76,000 x g at 4°C for 45 min through a 2 M 
sucrose cushion in the same buffer. The nuclei were resuspended in the 
1 x run-on buffer containing 5mM Tris-HCl, pH 7.5, 2.5 mM MgCI2, 
0.15 M KC1, 500 /,tM each of ATP, CTP, and GTP (Boehringer- 
Mannheim, Indianapolis, IN), 500/ICi [cz-S2P]UTP (NEN DuPont), 2.5 
/~M DTT, 40 U of RNAsin (Promega, Madison, WI), 5 mM 
phosphocretanine (Sigma), 100 ng/ml creatinine kinase (Sigma, St. 
Louis, MO), and 10 ktg/ml nucleotide diphosphate kinase (Sigma, St. 
Louis, MO). The reaction was carried out at 30°C for 30 min after 
which the reaction was stopped by adding 50 U of RNase-free DNase 
(Promega, Madison, WI) followed by another 5 min incubation. After 
the run-on reaction the radiolabeled RNA was isolated by using 
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RNazol (Biorecx, Houston, TX), isopropanol precipitated, washed 
with 70% ethanol and dissolved in DEPC-treated water. An aliquot of 
radiolabeled RNA isolated from different T cell samples was analysed 
in duplicates for free vs. incorporated radioactivity by TCA precipita- 
tion and an equal amount of radiolabeled RNA (in terms of TCA 
precipitable radioactivity) from different reatment conditions were 
hybridized to alkali-denatured plasmid DNA (5/lg), immobilized on 
Zetaprobe (Bio-Rad, Richmond, CA) membrane using a slot blot appa- 
ratus (Bio-Rad, Richmond, CA). Hybridization was carried out in a 
total volume of 500/A using 1 5 × l0 6 cpm/ml of hybridization solution 
(40% formamide, 4× SSC, 1 × Denhardt's, 5 mM EDTA, 0.4% SDS and 
100 pg/ml yeast RNA at 42°C for 3 days. Hybridization was preceded 
by prehybridization f slot blot filters in the hybridization solution for 
5-6 h. After hybridization, slot blot filters were first washed with 2× 
SSC, 0.1% SDS at room temperature for 30 min followed by three 
washes of 15 min each in 0.1× SSC, 0.1% SDS at 60°C and were 
autoradiographed for 3 7 days. 
2.5. Preparation of nuclear extracts for electrophoretic mobility shift 
assay 
The nuclear extracts were isolated as described [15]. In brief about 
15 x 106 T cells were suspended in 100 pl buffer containing 100 mM 
Tris-HC1, pH 7.5, 2.5 mM MgC12, 3 mM CaC12, 3 mM DTT and 3% 
sucrose. Following this, NP-40 was added to the final concentration f 
0.02% and the tube containing the cells was kept on ice for 5 min in a 
microfuge at 4°C. The supernatant was discarded and the nuclear pellet 
was resuspended in 100 pl of nuclear lysis buffer (20 mM HEPES, pH 
7.9, 0.2 M KC1, 1 mM EDTA, 1 mM DTT, 1 mM PMSF and 20% 
glycerol). Nuclei were extracted for 1 h at 4°C. The nuclear extracts 
were then centrifuged at 100,000 × g for 30 min at 4°C. Aliquots of the 
nuclear extracts were frozen in liquid nitrogen and stored at -70°C. 
Protein concentration of the nuclear extracts were determined by the 
Bradford method [17]. 
2.6. Electrophoretic mobility shift assay 
The binding reaction was carried out according to the method of Kim 
et al. [15] in a buffer containing 50 mM Tris-HC1, pH 7.5, 50 mM NaCI, 
5 mM MgC12, 1 mM DTT, 1 mM EDTA, 5% glycerol and 0.1 mM 
ZnC12 in a total volume of 20/A, using 5-10 ~tg of protein in the nuclear 
extract and 0.2 ng of 5' end-labeled ouble-stranded oligonucleotides 
in the presence of 1/tg of salmon sperm DNA at room temperature for 
20 min. In some experiments, the nuclear extracts were first incubated 
with a rabbit antiserum reactive with the Spl protein or with a control 
rabbit serum. Protein-DNA complexes were resolved using a 5% poly- 
acrylamide gel in 0.5x TBE, as described [12]. The gels were dried and 
exposed to X-ray films. The sequences of the different oligonucleotides 
(oligomers) used in this study were as follows: RCE, 5'-GGAGCCC- 
GCCCACGCGAGA-3' [11,12]; Spl, 5'-ATTCGATCGGGGCGGG- 
GCGAGA-3' (Promega, Madison, WI); NF-xB, 5'-GGGATTTCAC- 
CT-3' [15]. 
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Fig. 1. Stimulation of TGF-fll promoter activity by CsA. A-549 cells, 
transiently transfected with the TGF-fll promote~CAT gene chimeric 
construct, were treated with the reagents hown. TGF-fll promoter- 
driven CAT gene transcription was quantified by measuring CAT en- 
zyme protein concentration with a CAT-specific ELISA. Results 
(mean + S.E.M.) from 2-6 experiments (TGF-flt 5 ng/ml; CsA and CsH 
1 pg/ml). 
shown in Fig. 2 to illustrate the unique effect of CsA on TGF-fl~ 
gene transcription. CsA, in striking contrast o its effect on IL-2 
transcription, stimulated TGF-fl~ gene transcription in T cells 
incubated with ionomycin and DAG (Fig. 2). 
3.3. Differential expression of RCF-1 and RCF-2 in T cells and 
lack of inhibitory activity by CsA 
Transcript ion initiation is regulated by the binding of nuclear 
regulatory proteins to the enhancer/promoter r gion of a given 
gene. We therefore determined the effect of CsA on the emer- 
gence in T cells of DNA-binding proteins that bind to the 
Probe T+O T+I+DAG T+I+DAG+CsA 
pBlueseript 
3. Results 
3.1. Stimulation of TGF-fll promoter activity by CsA 
A chimeric construct (CAT gene fused to a functional TGF-  
fll promoter [9]) and the A-549 cells were used to characterize 
the effect of CsA on promoter-dependent TGF-fl~ transcrip- 
tion. The transiently transfected A-549 cells were either un- 
treated, or treated with CsA, CsH or TGF-fl l .  
Fig. 1 illustrates the effect of CsA, CsH or TGF-fl l  on TGF-  
fl~ promoter  activity. It is evident hat CsA stimulates TGF-fl~ 
promoter-dependent transcription of the CAT gene. It is also 
evident hat CsH, an inactive analogue of CsA [18], does not 
stimulate TGF-fl~-dependent transcription. Fig. 1 also shows 
that TGF-fl~, an inducer of TGF-fl,  expression [9], stimulates 
TGF-fl~ promoter activity. 
3.2. Stimulation of TGF-flt transcription by CsA 
Results from one of five nuclear run-on experiments are 
IL-2 
eDNA 
TGFpl 
eDNA 
~Actin 
Exonl-3 
Fig. 2. TGF-flj gene transcription stimulation by CsA. T cells were 
incubated alone (T + 0), with ionomycin and DAG (T + I + DAG), or 
were pretreated with CsA and then incubated with ionomycin and 
DAG (T + I + DAG + CsA). The nuclei were isolated and the nuclear 
run-on transcription reaction was performed in the presence of ~_32p_ 
labeled UTP. Whereas CsA pretreatment repressed the synthesis of 
IL-2 RNA transcripts, uch pretreatment stimulated the synthesis of 
TGF-fll RNA transcripts, fl-Actin gene transcription rate was quite 
similar in all three experimental conditions. This experiment is repre- 
sentative of five different experiments. 
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Fig. 3. Expression of RCF-1 and RCF-2 in T cells. Nuclear extracts, 
prepared from untreated or treated T cells, were incubated with 0~-32P - 
labeled s RCE (panel A) or Spl probe (panel B). (A) RCF-1 is present 
in equal amounts in the unstimulated T cells (lane 2), in T cells stimu- 
lated with ionomycin plus DAG (lane 3), and in T cells pretreated with 
CsA and then stimulated with ionomycin and DAG (lane 4). RCF-2 is 
absent in resting T cells (lane 2), emerges in the stimulated T cells (lane 
3), and the emergence ofRCF-2 is not inhibited by CsA (lane 4); RCF-1 
and RCF-2 are out-competed byan excess of unlabeled s RCE (lane 
5). An excess of unlabeled ds Spl competes for RCF-I only and not for 
RCF-2 (lane 6), and an excess of ds non-specific probe (NF-xB) does 
not compete for either RCF-1 or RCF-2 (lane 7). (B) Spl is present in 
equal amounts in resting T cells (lane 9), in stimulated T cells (lane 10) 
and in T cells pretreated with CsA and then stimulated (lane 11). 
Unlabeled excess ds RCE and the ds Spl compete for the Spl band 
(lanes 12, 13). An excess of non-specific probe NF-xB does not interfere 
with the formation of DNA-protein complexes. 
promoter region of TGF-fl~. Specifically, the emergence of 
RCF-1 and RCF-2 in the T cells was evaluated since these 
DNA-binding proteins target RCE located in the promoter 
region of the TGF-fl~ gene and regulate TGF-fl~ transcription 
in cell lines [12]. The emergence of RCF-1 and RCF-2 in T cells 
was determined using ds DNA oligomers corresponding to the 
RCE sequence. Since RCF-1 appears to be Spl, the emergence 
of nuclear protein(s) that bind the consensus Spl binding site 
was also determined. 
Results found with the RCE probe are shown in Fig. 3A. 
RCF-1 was clearly evident in the nuclear extracts isolated from 
unstimulated T cells, appeared to be a doublet and was neither 
increased nor decreased in the nuclear extracts of T cells that 
were either untreated or pretreated with CsA, prior to stimula- 
tion with ionomycin plus DAG (panel A, lanes 2, 3, and 4). 
RCF-2 was not detected in the unstimulated T cells (lane 2) and 
was clearly induced in the T cells stimulated with ionomycin 
plus DAG (lane 3). It is also shown in Fig. 3 that CsA does not 
prevent he emergence of RCF-2 in the stimulated T cells (lane 
3 vs. 4). 
The specificity of DNA-protein complexes formed is demon- 
strated by the finding that the binding of either RCF-1 or 
RCF-2 to RCE is prevented by the unlabeled RCE probe (lane 
5), and not by a non-specific probe (lane 7). That the RCF-1 
detected in the nuclear extract of T cells is indeed Sp 1 transcrip- 
tion factor is indicated by the finding that the formation of 
RCF-1-DNA complex is blocked by the unlabeled Spl probe 
(lane 6). Interestingly, Spl probe did not prevent RCF-2 bind- 
ing to RCE (lane 6). 
Results found with the Spl probe are illustrated in Fig. 3B. 
Spl was detected in unstimulated T cells (lane 9) and was not 
increased in T cells that were stimulated with ionomycin plus 
DAG (lane 10). Spl was also detected in T cells that were 
pretreated with CsA prior to stimulation (lane 11). The level of 
expression of Spl in CsA pretreated T cells was quite similar 
to that found in untreated cells and that found in T cells stim- 
ulated with ionomycin plus DAG (lanes 9-11). 
The specificity of the binding reaction shown is demonstrated 
by the ability of the unlabeled specific Spl probe to inhibit 
DNA-protein complex formation (lane 13) and the inability of 
the unlabeled non-specific probe to prevent he formation of 
the complex between the nuclear protein and the Spl probe 
(lane 14). In Fig. 3 it is also shown that the unlabeled RCE 
probe reduces the binding of Spl protein to the Spl probe (Fig. 
3B, lane 12). 
4. Discussion 
The new finding that has emerged from our study is that 
CsA, a well-characterized inhibitor of gene transcription, stim- 
ulates TGF-fll transcription i mammalian cells. 
Two independent and complementary lines of evidence sup- 
port the unique observation that CsA stimulates TGF-fl~ tran- 
scription. First, CsA stimulated TGF-fl~ promoter-dependent 
transcription of the CAT gene (Fig. 1). Second, CsA stimulated 
the synthesis of TGF-fl~ RNA transcripts in T cells incuba- 
ted with a synergistic ombination of DAG and ionomycin 
(Fig. 2). 
A high degree of specificity regarding CsA was clearly evi- 
dent in this study. CsA, and not CsH, an inactive analogue of 
CsA that has D-methylalanine instead of L-methylalanine at
amino acid position 11, stimulated TGF-fl~ promoter activity 
(Fig. 1). Also, the stimulatory effect of CsA was gene specific. 
Whereas TGF-fl~ gene transcription was stimulated by CsA, 
IL-2 gene transcription was inhibited in the same T cell popu- 
lation (Fig. 2). 
Studies exploring the mechanistic basis for the immunologi- 
cal activities of CsA have demonstrated that (i) cyclophilin, a
ubiquitously distributed protein and a peptidyl-prolyl cis-trans 
isomerase, is a cellular receptor for CsA; (ii) CsA-cyclophilin 
complex binds and inactivates calcineurin, a calcium- and calm- 
odulin-dependent serine-threonine phosphatase implicated in 
T cell signalling; and (iii) the emergence of NF-AT, a DNA 
binding protein and the induced expression of IL-2 gene are 
inhibited by CsA. Indeed, the ability of CsA to prevent IL-2 
expression iscurrently considered to be the primary mechanism 
of action of CsA. 
The NF-AT/IL-2 inhibition hypothesis [1,6], however, fails 
to offer a satisfactory explanation regarding the two well-docu- 
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mented complications of CsA: fibrosis and hypertension. Our 
demonstration that CsA stimulates TGF-fl] transcription ad- 
vances a novel mechanism not only for the immunosuppressive 
activity of CsA (since TGF-fl~ is a potent inhibitor of T cell 
activation) but also for fibrosis (since TGF-fl] is a fibrogenic 
cytokine) and hypertension (since TGF-fl~ stimulates the pro- 
duction of endothelin-1, a potent vasoconstrictor polypeptide 
[19]). 
Our studies on the emergence of DNA-binding proteins in 
primary T cells have also identified several novel features. First, 
CsA failed to inhibit activation-dependent emergence ofRCF-2 
in stimulated T cells (Fig. 3). This lack of inhibition is quite 
unique since CsA prevents the activation-dependent appear- 
ance of other DNA-binding proteins, like NF-AT [6,15], AP-1 
or NF-xB in primary T cells [15]. Second, RCF-2, detected in 
our stimulated T cells, appears to be a nuclear binding protein 
that is distinct from Spl since the Spl oligonucleotide probe 
competed for the binding of RCF-1 protein and not for that of 
RCF-2 protein to TGF-fll RCE (Fig. 3). 
The possibility that CsA promotes TGF-fl~ transcription by 
preventing the emergence of proteins that bind negative regula- 
tory elements in the TGF-flj promoter is not excluded by our 
current study. This postulate is worthy of exploration given the 
precedent that CsA stimulates laccase gene transcription i the 
fungus Cryphonectria parasitica [20] by interfering with the 
negative regulator of lac-1 promoter activity. 
In summary, results from this investigation demonstrate for 
the first time that CsA stimulates TGF-fl~ gene transcription i
mammalian cells. This stimulation is associated with an inabil- 
ity of CsA to prevent he emergence of RCF-2, a known regu- 
lator of TGF-fll transcription. 
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